Questioning Medicine – Détails, épisodes et analyse
Détails du podcast
Informations techniques et générales issues du flux RSS du podcast.


Join Andrew on a medical rollercoaster as we ask a medical question and answer it based on recent published papers.
Classements récents
Dernières positions dans les classements Apple Podcasts et Spotify.
Apple Podcasts
🇨🇦 Canada - medicine
16/09/2025#76🇨🇦 Canada - medicine
15/09/2025#42🇺🇸 États-Unis - medicine
08/12/2024#86
Spotify
Aucun classement récent disponible
Liens partagés entre épisodes et podcasts
Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.
See all- https://www.bing.com/ck/a?
486 partages
- https://doi.org/10.1016/S0140-6736
297 partages
Qualité et score du flux RSS
Évaluation technique de la qualité et de la structure du flux RSS.
See allScore global : 49%
Historique des publications
Répartition mensuelle des publications d'épisodes au fil des années.
Episode 351: 250. STROKE part 3 CME
Épisode 351
vendredi 29 novembre 2024 • Durée 09:11
STROKE part 3 CME
Episode 350: 249. STROKE - LA closure, alteplase vs tenecteplase, and thrombectomy
Épisode 350
mercredi 27 novembre 2024 • Durée 17:36
CME FOR FREEE
Episode 340: 339. Reaction Risk to Direct Penicillin Challenges
Épisode 340
mardi 29 octobre 2024 • Durée 05:52
10% of hospitalized patients have penicillin allergy listed in their records, fewer than 1% of patients have true allergies.
Use of more-expensive and broader-spectrum antibiotics is associated with longer and more-expensive hospital stays and more side effects, nosocomial infections, and resistant organisms.
Blumenthal KG et al. Reaction risk to direct penicillin challenges: A systematic review and meta-analysis. JAMA Intern Med 2024 Sep 16; [e-pub]. (https://doi.org/10.1001/jamainternmed.2024.4606)
researchers examined the safety of direct penicillin challenges (without preceding skin tests) for delabeling patients without true allergies. Among more than 9000 patients in these studies, 438 experienced reactions (3.5%), with only 5 reactions classified as severe: 3 episodes of anaphylaxis, 1 delayed rash with fever, and 1 kidney injury. No fatalities were reported.
NNH of 1800
The PENFAST score is a good tool to help decide which patients can undergo direct oral challenge safely (NEJM JW Gen Med Aug 1 2023 and JAMA Intern Med 2023; 183:883). In general, if a patient has a history of severe immediate reaction (angioedema or anaphylaxis), a recent urticarial reaction (within 5 years), or any severe delayed reaction (e.g., Stevens–Johnson syndrome, serum sickness, drug reaction with eosinophilia, drug-induced cytopenia, organ injury), I would refer to an allergist for evaluation.
Bottom line
We have far more patients who should have their penicillin allergy delabeled than we have allergists to perform these challenges. Primary care clinicians and hospitalists can do this easily by giving one dose of amoxicillin (500 mg) and watching the patient for 1 to 2 hours; intramuscular epinephrine and oral antihistamines must be available, but are seldom needed.
Episode 250: 250. Do Nurse Practitioners Prescribe More or Less Medications From the Beers List?
Épisode 250
vendredi 1 mars 2024 • Durée 05:15
Nurse Practitioners prescribe medications off the beers list at the same rate at primary care physicians, hard to tell what this means for patient care and patient outcomes.
https://www.acpjournals.org/doi/10.7326/M23-0827?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Episode 249: 249. Is There A Way To Predict Your Risk Of Dementia?
Épisode 249
jeudi 29 février 2024 • Durée 06:13
Using the Brain Care Score seem to be effective in predicting the risk of dementia
- For participants under 50, each five-point higher BCS is associated with a 50% lower risk of dementia or stroke
- For participants under 50, each five-point higher BCS is associated with a 59% lower risk of dementia
THE SCORE IS HERE ---->. https://www.massgeneral.org/assets/mgh/pdf/neurology/mccance-center/brain-care-score.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725202/#:~:text=A%20five%2Dpoint%20higher%20BCS,%25)%20among%20those%20aged%20%3E59.
Episode 248: 248. Should DAPT To Be Started >24hours After Minor Stroke OR High Risk TIA?
Épisode 248
mercredi 28 février 2024 • Durée 05:38
Even when starting DAPT within 72hours of symptom onset for individuals with minor stroke or TIA the benefit of DAPT for the first 21 days was still seen at 90 day follow up in the form of less recurrent stroke
https://www.nejm.org/do/10.1056/NEJMdo007334/full/
Episode 247: 247. Should Patients With Cancer Be On Primary Prevention VTE Prophylaxis?
Épisode 247
mardi 27 février 2024 • Durée 05:31
In those high risk patients -- usually with lung or GI cancer they did benefit from primary prevention VTE prophalaxis with a NNT of 6-7 for VTE and death at 6 months.
https://pubmed.ncbi.nlm.nih.gov/37733336/#:~:text=Conclusions%20and%20relevance%3A%20In%20this,safety%20concerns%2C%20and%20with%20reduced
Episode 246: 246. In Giant Cell Arteritis How Soon Do You Need To Get A Biopsy After Starting Steroids?
Épisode 246
vendredi 23 février 2024 • Durée 04:32
Just get he biopsy at less than 6 weeks after starting therapy as the yield was the same at 2 weeks as it was at 4-6 weeks
https://pubmed.ncbi.nlm.nih.gov/36642440/
Episode 245: 245. Do Baby Walkers Cause Developmental Delays?
Épisode 245
jeudi 22 février 2024 • Durée 20:14
Evidence against baby walker is not enough regarding its negative effect on child development. This subject needs to be addressed more, considering a large number of baby walker users worldwide.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703622/
Surveillance System data from 1990 to 2014
230 676 children <15 months old were treated for infant walker–related injuries in US emergency departments from 1990 to 2014.
9 out of every 10 injuries were to the head and neck and 74% were injuries secondary to falling down the stairs in an infant walker
https://publications.aap.org/pediatrics/article-abstract/142/4/e20174332/37420/Infant-Walker-Related-Injuries-in-the-United?redirectedFrom=fulltext?autologincheck=redirected
Episode 244: 244. Does Testosterone CAUSE Prostate Cancer?
Épisode 244
mardi 20 février 2024 • Durée 04:55
During average follow-up of in this study the incidence of prostate cancer was less than 1% — and not significantly different
Remember most of these pts had testosterone levels around 350 ish give or take so the safety of longer-duration treatment — or treatment resulting in higher blood levels of testosterone — remains unclear.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2813293









